Supernus Pharmaceuticals (SUPN) Q2 2017 Earnings

9MayConfirmed
Q2 2016
Q3 2016
Q1 2017
Q2 2017
0.08
0.14
0.21
0.27

Details

Expected EPS
0.21
Actual EPS
0.19
Surprise EPS
-0.02
Surprise Percent
+9.52%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.19 per share for Q2 2017.

0 Comments

Share your thoughts